Cytokinetics Inc (CYTK)
47.67
-2.19
(-4.39%)
USD |
NASDAQ |
Nov 21, 16:00
47.82
+0.15
(+0.31%)
After-Hours: 06:42
Cytokinetics 1 Year Total Returns (Daily): 50.19% for Nov. 21, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 21, 2024 | 50.19% |
November 20, 2024 | 54.32% |
November 19, 2024 | 57.49% |
November 18, 2024 | 60.11% |
November 15, 2024 | 52.97% |
November 14, 2024 | 59.52% |
November 13, 2024 | 74.82% |
November 12, 2024 | 72.89% |
November 11, 2024 | 80.37% |
November 08, 2024 | 66.80% |
November 07, 2024 | 55.76% |
November 06, 2024 | 61.20% |
November 05, 2024 | 44.60% |
November 04, 2024 | 41.74% |
November 01, 2024 | 47.64% |
October 31, 2024 | 46.30% |
October 30, 2024 | 59.89% |
October 29, 2024 | 62.29% |
October 28, 2024 | 64.65% |
October 25, 2024 | 57.47% |
October 24, 2024 | 64.47% |
October 23, 2024 | 66.37% |
October 22, 2024 | 65.93% |
October 21, 2024 | 62.52% |
October 18, 2024 | 60.26% |
Date | Value |
---|---|
October 17, 2024 | 54.13% |
October 16, 2024 | 59.54% |
October 15, 2024 | 61.88% |
October 14, 2024 | 59.31% |
October 11, 2024 | 52.66% |
October 10, 2024 | 52.42% |
October 09, 2024 | 71.61% |
October 08, 2024 | 77.55% |
October 07, 2024 | 81.27% |
October 04, 2024 | 109.5% |
October 03, 2024 | 107.3% |
October 02, 2024 | 88.70% |
October 01, 2024 | 78.55% |
September 30, 2024 | 79.23% |
September 27, 2024 | 74.93% |
September 26, 2024 | 75.43% |
September 25, 2024 | 75.72% |
September 24, 2024 | 70.15% |
September 23, 2024 | 68.30% |
September 20, 2024 | 68.19% |
September 19, 2024 | 68.84% |
September 18, 2024 | 65.16% |
September 17, 2024 | 64.07% |
September 16, 2024 | 65.79% |
September 13, 2024 | 60.44% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-47.41%
Minimum
Oct 03 2023
178.1%
Maximum
Mar 18 2021
51.98%
Average
58.30%
Median
1 Year Total Returns (Daily) Benchmarks
Ocugen Inc | 132.8% |
Scholar Rock Holding Corp | 124.9% |
Mirum Pharmaceuticals Inc | 35.88% |
NeuroBo Pharmaceuticals Inc | -31.69% |
Edgewise Therapeutics Inc | 404.4% |